Clinical trials recruiting for Multiple Sclerosis (MS)
14
Recruiting trials
4
US states with sites
7
Countries
29%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 18F-OP-801 | 1 |
| CD20/BCMA-directed CAR-T cells | 1 |
| Clemastine Fumarate | 1 |
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| Metformin | 1 |
| Universal CD19 CAR-γδT Cell Injection | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Florida | 1 |
| New York | 1 |
| Washington | 1 |
Top cities
San Francisco, California 2Jacksonville, Florida 1New York, New York 1Seattle, Washington 1Stanford, California 1
Self-screener
Recruiting trials
- A Palliative Care Model Impact on Knowledge and Attitudes
- A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
- Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
- Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
- Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
- MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis
- Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
- Pregnancy Cohort in Multiple Sclerosis (MS)
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences
- Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
Related conditions
Trials recruiting for Multiple Sclerosis (MS) often also study these conditions. Each links to its own recruiting-trial list.
Multiple sclerosis 445Systemic Sclerosis (SSc) 28Systemic lupus erythematosus 119Secondary-progressive Multiple Sclerosis (SPMS) 4Relapsing-remitting Multiple Sclerosis (RRMS) 6Physical Inactivity 24Parkinson's disease 522Parkinson Disease (PD) 33Neuromyelitis Optica Spectrum Disorders 5Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Multiple Sclerosis (MS) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.